Group 1 - The Financial 15 Split Corp. has completed an overnight offering of Preferred Shares, raising approximately $92.2 million in gross proceeds [1][2] - The offering price for the Preferred Shares is set at $10.60, with the closing price on the TSX being $10.72 as of November 17, 2025 [2] - The net proceeds from the offering will be invested in a high-quality portfolio of financial services companies, including major Canadian and U.S. banks and financial institutions [3] Group 2 - A prospectus supplement will be filed with securities commissions in all provinces of Canada, providing detailed information about the Preferred Shares and Class A Shares being offered [4] - Starting December 1, 2025, holders of the Preferred Shares will receive fixed, cumulative monthly dividends at an annual rate of 7.25%, with a minimum rate of 6.00% until 2030 [5] - On or about the termination date of December 1, 2030, holders of the Preferred Shares will be paid $10.00 per share [5]

Core Viewpoint - Medexus Pharmaceuticals has announced a new senior secured credit agreement totaling US$51.0 million, which includes a US$21.0 million term loan and a US$5.0 million revolving loan facility, alongside plans to initiate a normal course issuer bid (NCIB) for its common shares [1][2][3]. Group 1: Credit Facilities - The new credit agreement includes a US$21.0 million term loan facility and a US$5.0 million revolving loan facility, with an additional US$10.0 million delayed draw feature for future licensing and acquisition transactions [1]. - The term loan facility has a maturity date of November 17, 2029, and the weighted average interest rate will initially be 6.74%, which is lower than the previous rate of 6.95% [2]. Group 2: Normal Course Issuer Bid (NCIB) - Medexus intends to commence an NCIB for its common shares, subject to approval from the Toronto Stock Exchange (TSX), allowing the company to purchase up to 10% of its public float over the next 12 months [3]. - The actual number of shares purchased under the NCIB will depend on market conditions and the company's discretion, with the aim of stabilizing the market for its common shares [4]. Group 3: Financial and Operational Outlook - The CFO of Medexus highlighted the significance of the new financing as a non-dilutive option that reflects the company's improving financial and operational profile since the launch of GRAFAPEX™ in February 2025 [2]. - The company is focused on capital allocation strategies that may include share repurchases if the market price is deemed undervalued, which could benefit both the company and its investors [4]. Group 4: Company Overview - Medexus is a leading specialty pharmaceutical company with a strong North American commercial platform, focusing on innovative treatments in hematology, hematology-oncology, rheumatology, and allergy [4].

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value investors use fundamental analysis and traditional valuation metrics to fin ...

Core Insights - Global equity markets experienced significant growth in Q3, with the S&P 500 rising 8.12% for the quarter and 14.83% year-to-date, while the MSCI EAFE Index increased by 4.77% for the quarter and 25.14% year-to-date [2][3] Market Performance - The S&P 500 achieved back-to-back annual returns of 26% and 25% in 2023 and 2024, respectively, with valuation metrics like the "Buffett Indicator" and CAPE-Shiller P/E at or near record highs [2] - Non-US equities, particularly European stocks, outperformed the S&P 500 year-to-date, benefiting from a weaker US dollar and a resurgence in value recognition [3][11] Fund Performance - Tweedy, Browne Funds reported year-to-date returns ranging from 15.98% for the Value Fund to 23.17% for the International Value Fund II, with the Worldwide High Dividend Yield Value Fund outperforming its benchmark [3][5] - The International Value Fund II had a return of 23.17%, trailing its benchmark, the unhedged MSCI EAFE Index, by 197 basis points [3] Portfolio Activity - The company made strategic adjustments to its portfolio, trimming or selling holdings that reached estimated value and adding to companies perceived as attractively priced, such as Berkeley Group Holdings and Breedon Group [8] - New positions were initiated in Santec Holdings and additional investments were made in companies like Dentium and Azelis Group, reflecting a focus on growth potential and reasonable valuations [8] Outlook - The company is optimistic about the resurgence of non-US equity returns and believes its funds are well-positioned for future market conditions, whether they favor non-US equities or face broader market challenges [11]

Group 1 - BMO Capital Markets led the M&A financial advisory rankings in the metals and mining sector for Q1–Q3 2025, advising on 12 deals valued at $7.3 billion, securing the top position in both deal value and volume [1][2] - BMO Capital Markets was the only adviser to achieve double-digit deal volume during this period, advising on three billion-dollar deals [2] - JP Morgan followed in deal value with transactions worth $5.5 billion, while CIBC Capital Markets, National Bank of Canada, and GenCap Mining Advisory completed the top five with deal values of $4.4 billion and $2.6 billion, respectively [2] Group 2 - In terms of deal volume, Evans & Evans secured the second position with seven deals, while Beaumont Cornish also completed seven deals but ranked third due to lesser-value deals [3] - CIBC Capital Markets and SP Angel Corporate Finance took the fourth and fifth spots in deal volume, both advising on six deals, with CIBC ranking higher due to greater deal value [3] Group 3 - GlobalData's league tables are based on real-time tracking of various reliable sources, with a dedicated team of analysts monitoring these sources to gather detailed information on each deal [4]

Core Insights - RBC ranks highest in customer satisfaction among the Big 5 Canadian banks for the second consecutive year, followed by CIBC, BMO, TD, and Scotiabank [1] - Tangerine Bank leads among midsize banks for the 14th consecutive year, ahead of Simplii, National Bank of Canada, Desjardins, and ATB [1] Customer Satisfaction Trends - The 2025 survey indicates a decline in customer satisfaction among the Big 5 banks, dropping 7 points to 604 on a 1,000-point scale, while midsize banks saw an increase of 5 points to 649, widening the satisfaction gap [2] - Despite the downward trend, Big 5 banks maintain a significant share of the consumer market due to factors like branch convenience and effective communication [3] Key Performance Metrics - Improvement in problem resolution is noted, with satisfaction increasing by 19 points for midsize banks and 13 points for Big 5 banks [4] - New account opening satisfaction has declined, with Big 5 banks dropping 17 points and midsize banks dropping 7 points, highlighting issues in representative knowledge and product clarity [4] - Customer loyalty is showing signs of softening, with the percentage of customers switching their primary banking relationship rising to 7% from 6% over the past three years, driven by poor service, high fees, and competitive offers [4]

Core Viewpoint - Life & Banc Split Corp. is planning a stock split of its class A shares due to strong performance, with the split expected to take effect on October 27, 2025 [1][4]. Group 1: Stock Split Details - Class A shareholders will receive 10 additional class A shares for every 100 shares held as part of the stock split [1]. - The stock split is subject to approval from the Toronto Stock Exchange [1]. - The stock split is a non-taxable event, and no fractional shares will be issued [4]. Group 2: Shareholder Benefits - Following the stock split, class A shareholders will continue to receive monthly cash distributions targeted at $0.10 per share, leading to an expected increase of approximately 10% in total distributions [2]. - The Fund offers a distribution reinvestment plan for class A shareholders to reinvest distributions without commission [2]. Group 3: Performance Metrics - Over the past 10 years, class A shares have delivered a total return of 20.5% per annum, outperforming the S&P/TSX Capped Financials Total Return Index by 6.8% and the S&P/TSX Composite Total Return Index by 8.7% [3]. - Since inception, class A shareholders have received cash distributions totaling $20.95 per share [3]. Group 4: Fund Composition - The Fund invests equally in common shares of the six largest Canadian banks and four major publicly traded Canadian life insurance companies [5]. - The portfolio includes notable institutions such as the Royal Bank of Canada and Manulife Financial Corporation [5]. Group 5: Risk Mitigation - Preferred shares of the Fund are expected to have downside protection of approximately 52% against declines in the value of the Fund's portfolio [4].

Core Viewpoint - Brompton Split Banc Corp. is set to execute a stock split of its class A shares due to strong performance, with class A shareholders receiving additional shares on a specified date [1][4]. Group 1: Stock Split Details - The class A shareholders of record on October 27, 2025, will receive 17 additional class A shares for every 100 shares held [1]. - The stock split is subject to approval from the Toronto Stock Exchange [1]. - The class A shares will commence trading on an ex-split basis on October 27, 2025, with no fractional shares issued [4]. Group 2: Financial Performance - Over the past 10 years, class A shares have delivered an 18.4% annual total return based on net asset value, outperforming the S&P/TSX Equal Weight Diversified Banks Total Return Index by 5.1% and the S&P/TSX Composite Total Return Index by 6.6% [3][7]. - Class A shareholders have received cash distributions totaling $23.45 per share since inception [3]. Group 3: Distribution and Growth - Following the stock split, class A shareholders will continue to receive monthly cash distributions targeted at $0.10 per share, leading to an expected increase of approximately 17% in total distributions [2]. - The Fund offers a distribution reinvestment plan for class A shareholders to reinvest distributions and benefit from compound growth [2]. Group 4: Investment Strategy - The Fund invests in an approximately equal-weighted portfolio of common shares from the six largest Canadian banks, with up to 10% of total assets in global financial companies for diversification [5].

Energy Sector & International Relations - Canada is positioned as an energy superpower [1] - National Bank suggests Canada is the best partner for US industrialization [1] Economic & Industrial Strategy - The US has the potential to industrialize further [1]

Event Announcement - Bloomberg Canadian Finance 会议正在进行中 [1] Participants - Yves Poirier (@CanadaNY), Stéfane Marion (National Bank of Canada), Aida Cipolla (@opg), David Timm (@northlandpower) 等参与了此次会议 [1]